Skip to main content

Diagnostic options Β· UAE

Inherited Disorders tests in Dubai & UAE

Compare available Inherited Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

10

Listed price range

2,800.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Inherited Disorders test prices

Showing 1–10 of 10 matching tests.

Inherited Disorders diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3730
ABCD1 Gene Adrenoleukodystrophy (X-Linked) Test

This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD). It provides definitive diagnosis and carrier status determina...

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCD1 gene", "Point mutations", "Small insertions/deletions", "Large copy number variations"]
Parameters
[]
Preparation
["A prior genetic counseling appointment is mandatory.", "A detailed three-generation pedigree chart is mandatory."]
Indications
["Suspected X-linked adrenoleukodystrophy (X-ALD)", "Family history of X-ALD", "Carrier screening", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93119-6 ICD-10: E71.52
Clinical summary
This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD). It provides definitive diagnosis and carrier status determination.
TEST-6051
BCHE Gene Butyrylcholinesterase Deficiency Genetic Test

This genetic test evaluates the BCHE gene for mutations associated with butyrylcholinesterase deficiency, an inherited condition affecting anesthetic metabolism.

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3–4 Weeks (21–28 Calendar Days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["BCHE gene sequence", "Pathogenic mutations in the BCHE gene"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Preoperative screening for patients undergoing surgery requiring succinylcholine or mivacurium", "Evaluation of individuals with a family history of pseudocholinesterase deficiency", "Diagnosis of unexplained prolonged paralysis following anesthesia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21671-0 ICD-10: E70.3
Clinical summary
This genetic test evaluates the BCHE gene for mutations associated with butyrylcholinesterase deficiency, an inherited condition affecting anesthetic metabolism.
TEST-6048
MANBAL Gene (Mannosidosis, Beta A, Lysosomal) Genetic Test

This genetic test identifies pathogenic variants in the MANBA gene associated with Beta-Mannosidosis.

Whole Blood (EDTA tube), Buccal Swab, FTA Card, or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the MANBA gene", "Point mutations", "Small insertions/deletions (indels)", "Copy number variations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab if patient received blood transfusion within 4 weeks"]
Indications
["Confirmation of molecular diagnosis", "Carrier testing", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83136-1 ICD-10: E77.1
Clinical summary
This genetic test identifies pathogenic variants in the MANBA gene associated with Beta-Mannosidosis.
TEST-4794
NLRP3 Gene Muckle-Wells Syndrome Genetic Test

This test identifies pathogenic variants in the NLRP3 gene associated with Muckle-Wells Syndrome.

Whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NLRP3 gene"]
Parameters
[]
Preparation
["Attend pre-test genetic counseling session", "Construct a detailed pedigree chart"]
Indications
["Confirming clinical suspicion of Muckle-Wells Syndrome", "Guiding anti-interleukin-1 therapy", "Recurrence risk counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96410-7 ICD-10: E85.0
Clinical summary
This test identifies pathogenic variants in the NLRP3 gene associated with Muckle-Wells Syndrome.
TEST-3106
Noonan-RASopathies Panel Genetic Test

This test identifies germline mutations in 22 genes associated with RASopathies, including Noonan syndrome and neurofibromatosis type 1.

Whole Blood (EDTA, 3-5 mL), Extracted DNA (β‰₯1 Β΅g), or FTA Card 3 to 4 Weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Germline mutations", "Variants in 22 genes (BRAF, CBL, HRAS, KAT6B, KRAS, LZTR1, MAP2K1, MAP2K2, NF1, NF2, NRAS, PTPN11, RAF1, RASA2, RIT1, SHOC2, SMARCB1, SOS1, SOS2, SPRED1, TSC1, TSC2)"]
Parameters
[]
Preparation
[]
Indications
["Suspected Noonan syndrome", "Suspected cardiofaciocutaneous syndrome", "Suspected Costello syndrome", "Suspected Legius syndrome", "Suspected neurofibromatosis type 1"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92718-9 ICD-10: Q87.1, Q87.19
Clinical summary
This test identifies germline mutations in 22 genes associated with RASopathies, including Noonan syndrome and neurofibromatosis type 1.
TEST-3086
NOTCH2 Gene Alagille Syndrome Type 2 Genetic Test

This genetic test analyzes the NOTCH2 gene to identify mutations associated with Alagille syndrome type 2.

Peripheral Whole Blood (EDTA) or Extracted Genomic DNA 21-28 Days (Expedited options available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["NOTCH2 gene sequence", "Presence of pathogenic variants"]
Parameters
[]
Preparation
[]
Indications
["Suspected Alagille syndrome type 2", "Family history of Alagille syndrome", "Need for genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94391-3 ICD-10: Q44.7, Z13.89
Clinical summary
This genetic test analyzes the NOTCH2 gene to identify mutations associated with Alagille syndrome type 2.
TEST-4044
NSDHL Gene CHILD Syndrome Genetic Test (NGS)

This test detects pathogenic variants in the NSDHL gene to confirm a diagnosis of CHILD syndrome.

Peripheral whole blood (EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NSDHL gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent allogeneic bone marrow transplantation"]
Indications
["Individuals with clinical features of CHILD syndrome", "Female carriers with a family history", "Mothers of affected boys", "Couples planning pregnancy seeking preimplantation genetic diagnosis", "Newborns with suggestive skin findings"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21621-4 ICD-10: Q87.2
Clinical summary
This test detects pathogenic variants in the NSDHL gene to confirm a diagnosis of CHILD syndrome.
TEST-2227
POLR1C Gene Treacher Collins Syndrome Type 3 Genetic Test

This test evaluates the POLR1C gene for pathogenic variants associated with Treacher Collins syndrome type 3 (TCS3). It uses Next-Generation Sequencing (NGS) to analyze the entire...

Peripheral whole blood (3–5 mL in EDTA tube), FTA card, or extracted DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["POLR1C gene coding regions", "POLR1C gene splice sites", "Pathogenic variants"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session required"]
Indications
["Clinical features of Treacher Collins syndrome type 3", "Known family history of TCS3", "At-risk relatives after genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81266-1 ICD-10: Q75.4
Clinical summary
This test evaluates the POLR1C gene for pathogenic variants associated with Treacher Collins syndrome type 3 (TCS3). It uses Next-Generation Sequencing (NGS) to analyze the entire coding region and splice sites.
TEST-3350
RFX5 Gene (Bare Lymphocyte Syndrome Type 2) Genetic Test

This test identifies pathogenic variants in the RFX5 gene associated with Bare Lymphocyte Syndrome Type 2 (MHC Class II Deficiency), a severe combined immunodeficiency.

Peripheral Whole Blood (Venipuncture) or Dried Blood Spot (FTA Card) 3–4 Weeks (21–28 Business Days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the RFX5 gene", "Copy number variations in the RFX5 gene"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the phlebotomist of any current medications."]
Indications
["Suspected Bare Lymphocyte Syndrome Type 2 (MHC Class II Deficiency)", "Family screening for RFX5-related immunodeficiency", "Diagnosis of severe combined immunodeficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21668-8 ICD-10: D82.1
Clinical summary
This test identifies pathogenic variants in the RFX5 gene associated with Bare Lymphocyte Syndrome Type 2 (MHC Class II Deficiency), a severe combined immunodeficiency.
TEST-3708
SCNN1G Gene Liddle Syndrome Genetic Test (NGS)

This test identifies pathogenic variants in the SCNN1G gene associated with Liddle syndrome, a form of genetic hypertension.

Whole blood (EDTA), extracted genomic DNA, or dried blood spot on FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SCNN1G gene variants", "Pathogenic single-nucleotide variants", "Small insertions and deletions", "Copy-number variants"]
Parameters
[]
Preparation
["No fasting required", "Provide signed genetic counseling consent form", "Provide three-generation pedigree chart"]
Indications
["Diagnosis of Liddle syndrome", "Evaluation of unexplained early-onset hypertension", "Family cascade screening for Liddle syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98118-1 ICD-10: I10, Z13.71
Clinical summary
This test identifies pathogenic variants in the SCNN1G gene associated with Liddle syndrome, a form of genetic hypertension.

Category overview

Inherited Disorders: overview

A family history of chronic illness, undiagnosed multi-system issues, or overlapping generational symptoms warrants proactive, empowering insights to break the cycle and protect your future health. Integrated into our comprehensive Genetics department, testing for broad Inherited Disorders evaluates your DNA for a vast spectrum of familial mutations passed down through your family tree. By leveraging state-of-the-art sequencing technology, this expansive molecular profiling helps identify hidden molecular risks long before symptoms escalate, safely guiding your healthcare provider in tailoring highly personalized preventative care, customized medical therapies, and proactive family planning. Recognized for preventative diagnostic excellence among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, uncompromising diagnostic precision, and highly efficient reporting. Take an empowered step toward targeted wellnessβ€”book your inherited disorders testing in UAE, arrange a secure home sample collection, or connect with our specialized medical genetics team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.